The Src substrate CTTN has been found to be overexpressed in various cancers, including human colorectal cancer, esophageal tumors, and non-small-cell lung cancer, and HCC and CTTN overexpression closely correlates with tumor aggressiveness, cell adhesion, and cell motility37–42. This evidence concerns the gene SRC and hepatocellular carcinoma.